ArticleBreast care (Basel, Switzerland)2023

Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer Patients.

Adela-Luciana Oprea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.